Cambiar Investors LLC Has $4.96 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Key Points

• Cambiar Investors LLC increased its position in DENTSPLY SIRONA by 7.3%, owning approximately $4.96 million worth of shares as of the latest SEC filing.
• Following several adjustments, 95.70% of DENTSPLY SIRONA's stock is now owned by institutional investors and hedge funds, indicating strong institutional interest.
• Analysts have given a consensus rating of "Hold" for DENTSPLY SIRONA's stock, with an average price target of $18.64.

Cambiar Investors LLC increased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 7.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 331,767 shares of the medical instruments supplier's stock after purchasing an additional 22,557 shares during the period. Cambiar Investors LLC owned approximately 0.17% of DENTSPLY SIRONA worth $4,957,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in DENTSPLY SIRONA by 2.8% in the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier's stock valued at $309,864,000 after acquiring an additional 557,329 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in DENTSPLY SIRONA by 18.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after acquiring an additional 1,975,404 shares in the last quarter. Fuller & Thaler Asset Management Inc. raised its holdings in DENTSPLY SIRONA by 2.8% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier's stock valued at $219,018,000 after acquiring an additional 314,343 shares in the last quarter. Lazard Asset Management LLC raised its holdings in DENTSPLY SIRONA by 23.0% in the 4th quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier's stock valued at $152,678,000 after acquiring an additional 1,505,928 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of DENTSPLY SIRONA by 21.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 6,851,869 shares of the medical instruments supplier's stock valued at $130,045,000 after purchasing an additional 1,230,944 shares during the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on XRAY. Wells Fargo & Company decreased their price target on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research note on Friday, August 8th. UBS Group decreased their price target on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Wall Street Zen lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Finally, Barrington Research set a $18.00 price objective on DENTSPLY SIRONA and gave the stock an "outperform" rating in a research report on Friday, August 8th. Twelve investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $18.64.

DENTSPLY SIRONA Stock Down 0.1%

Shares of DENTSPLY SIRONA stock opened at $13.85 on Friday. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $27.48. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The stock's 50-day moving average is $15.46 and its 200 day moving average is $15.69. The firm has a market cap of $2.76 billion, a price-to-earnings ratio of -2.92, a PEG ratio of 0.86 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%. The business had revenue of $936.00 million for the quarter, compared to the consensus estimate of $929.67 million. During the same period in the prior year, the business earned $0.49 EPS. The firm's revenue for the quarter was down 4.9% on a year-over-year basis. Equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date of this dividend is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio is -13.50%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.